about
Andropause. Testosterone replacement therapy for aging menBone mass is preserved and cancellous architecture altered due to cyclic loading of the mouse tibia after orchidectomy.A mineral-rich extract from the red marine algae Lithothamnion calcareum preserves bone structure and function in female mice on a Western-style diet.Adverse effects of androgen deprivation therapy: defining the problem and promoting health among men with prostate cancer.Bone health and prostate cancer.Application of a fracture risk algorithm to men treated with androgen deprivation therapy for prostate cancerManagement of complications of prostate cancer treatment.Optimizing bone health and minimizing skeletal morbidity in men with prostate cancerTreatment and prevention of bone complications from prostate cancer.Androgen deprivation therapy for prostate cancer: new concepts and concerns.Treatment-related osteoporosis in men with prostate cancer.Androgen deprivation therapy for the treatment of prostate cancer: consider both benefits and risksContemporary therapeutic approaches targeting bone complications in prostate cancerRANKL-Targeted Therapies: The Next Frontier in the Treatment of Male Osteoporosis.Living with a `women's disease': risk appraisal and management among men with osteoporosis.The Anti-Inflammatory, Phytoestrogenic, and Antioxidative Role of Labisia pumila in Prevention of Postmenopausal Osteoporosis.Eurycoma longifolia: Medicinal Plant in the Prevention and Treatment of Male Osteoporosis due to Androgen Deficiency.The effects of tualang honey on bone metabolism of postmenopausal women.Approach to the prostate cancer patient with bone diseaseRelationship of sex steroid hormones with bone mineral density (BMD) in a nationally representative sample of men.Factors associated with vertebral fractures in men treated with androgen deprivation therapy for prostate cancerEmerging therapies to prevent skeletal morbidity in men with prostate cancer.The osteoporotic male: overlooked and undermanaged?Bone-targeted agents: preventing skeletal complications in prostate cancer.Prostate cancer survivorship: prevention and treatment of the adverse effects of androgen deprivation therapy.Denosumab is really effective in the treatment of osteoporosis secondary to hypogonadism in prostate carcinoma patients? A prospective randomized multicenter international study.Bone-targeting radiopharmaceuticals for the treatment of prostate cancer with bone metastases.Aberrant tryptophan transport in cultured fibroblast from patients with Male Idiopathic Osteoporosis: An in vitro study.A Prospective, Observational Study of Osteoporosis in Men.Physical activity and inactivity and risk of hip fractures in men.Treatment of osteoporosis in menOsteoporosis in men
P2860
Q28352150-E76D7671-4702-4753-BA66-4C88990D964CQ33330451-5D7ACAB5-8D0D-4F47-A3AE-17DEEF64FB31Q33881006-1C69D620-61E3-443D-96C7-14EA330A8374Q33977523-0ED55BBE-34C3-4742-9FF8-30C6F76B0CE2Q33977536-12DC0CBB-2F4A-41B8-9B0F-9D30BC108375Q33977543-CE74354D-7432-499A-915F-D2885DDA40B5Q33978360-D510D5EC-2CAF-41F8-9A56-B888863B6D18Q34023510-2D17D3E6-6148-40D0-A741-A81CA2A42BE6Q34441944-8F2A6BF4-982A-4074-8A96-E47A939D8BA1Q34617845-9A1FC6A4-4CF1-4838-B0FF-35CB28348BA4Q34617878-D1A42767-9258-447A-8AC4-6B3F7B9E679BQ34960686-72FC85DC-61F8-458C-82ED-45555E398B28Q34960778-0442CDDD-BDAD-4F2D-A5B1-4C414363F851Q35380592-1DB1A487-EB20-4FFA-BC6D-1F9427D378CEQ35572841-37A46DEA-8210-47DE-8C7A-E61653C94B2FQ35963142-50D198ED-FD44-47C6-9E7D-EA9581B70A71Q36111388-8C532718-35AC-4C31-AC42-5BB4F6E8A492Q36222205-36420395-8476-42D3-945F-52DBABD7ED95Q36360754-F13F071D-7CD9-4842-8D58-AE7CA2D0B92AQ36387995-E6BADE06-6610-4AE6-AA0F-BCD777A80E25Q36892956-18BB041F-5A3C-44CE-B2D6-1B95838CA6C4Q36910469-D60566F4-0366-4F9E-BF8C-D460E024F338Q37017423-83E89580-0ED3-469F-B67A-429794348A28Q37039594-F5487352-9C63-4250-8ACE-81AA12DD9318Q37390104-0FC9486C-EA87-43CF-997A-E43BC778142BQ37653255-00C9899C-3D06-497A-9FEA-806B66A5DEFCQ38004275-9B7B903B-6F0A-4EF2-8B80-4378890DF2BBQ47555054-CB11C97F-7D70-4A1D-8344-B81278E0F989Q52657012-2A8471D2-1C17-4294-9A0F-86630C9E439DQ55497233-14C10711-7B59-4A3E-B862-B9AF954CFD3FQ56109539-F9702160-EADE-4B27-BB8E-6DE92DC36746Q56110001-280614D9-A3AC-465C-BF44-BD1F24F509A1
P2860
description
1999 nî lūn-bûn
@nan
1999 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
1999 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
1999年の論文
@ja
1999年論文
@yue
1999年論文
@zh-hant
1999年論文
@zh-hk
1999年論文
@zh-mo
1999年論文
@zh-tw
1999年论文
@wuu
name
Osteoporosis in men.
@ast
Osteoporosis in men.
@en
type
label
Osteoporosis in men.
@ast
Osteoporosis in men.
@en
prefLabel
Osteoporosis in men.
@ast
Osteoporosis in men.
@en
P356
P1476
Osteoporosis in men.
@en
P2093
Bilezikian JP
P304
P356
10.1210/JCEM.84.10.6060
P407
P577
1999-10-01T00:00:00Z